The global financial and macroeconomic crisis of / and the ensuing recessions obliged policy makers to maximize use of resources. Healthcare's value chain has typically grown over time, leading to high levels of duplication of providers and very disjointed services in general. J Spinal Disord Tech. Oct;28(8) doi: /BSD Understanding a Value Chain in Health Care. Sharan AD(1), Schroeder GD.


Author: Karley Doyle
Country: Vanuatu
Language: English
Genre: Education
Published: 14 August 2014
Pages: 664
PDF File Size: 44.40 Mb
ePub File Size: 3.7 Mb
ISBN: 996-2-70747-824-9
Downloads: 84828
Price: Free
Uploader: Karley Doyle


The study goes on to provide feasible recommendations aimed at maximizing provision of health-care services in Healthcare value chain. Governments are, therefore, increasingly scrutinizing returns on health-care expenditure and pushing health actors to reorganize inefficient and badly functioning public systems.

There is an increasing need for a synergistic set of policies, which requires joint action of health and non-health sectors, of public and private actors and of citizens for a common healthcare value chain.

The challenges are greater for small states as these do not have a large portfolio of institutions to provide health-care services.

Indeed, in a narrative literature review on policy challenges and reforms in small European Union EU member states, Azzopardi-Muscat et al.

What is Healthcare's Value Chain? A Lesson from Porter

Therefore, so as to maximize the provision of healthcare value chain delivery as well as to ensure health system resilience, small states must endorse the active involvement of all institutions that are relevant to health-care delivery, irrespective of whether healthcare value chain are public or private entities.

In view of emerging evidence that effective channels improve public hospital performance, some suggest that hospital competition should be nurtured 7.


On the other hand, others healthcare value chain that the strategies that promote competition may not lead to improved quality due to a dominating price competition, with purchasers and consumers preferring lower premiums at the expense of improved quality 8.

Moreover, competition between providers may be asymmetric 9in that, if the public sector provides excellent health-care delivery then the private healthcare value chain sector loses competitive advantage; if the private health-care sector is successful, then pressure on the public sector is reduced.

This empirical study aims to identify and analyze complementary and mutual attributes in the value creation healthcare value chain to patients by the public and private health-care systems in Malta, a small EU island State, through workshop settings involving a wide array of professionals from both sectors.

Through an analysis of strengths, weaknesses, opportunities, and threats SWOTwe explored the strengths and weaknesses of the internal environment and the opportunities and threats of the external environment of both sectors in an attempt to provide recommendations aimed at maximizing provision of health-care services in Malta.

Public—private collaboration has become widespread healthcare value chain as an approach for improving all the dimensions of good quality in health-care delivery, as defined by healthcare value chain Institute of Medicine, namely safe, effective, timely, efficient, equitable, and people-centered care 1112while aiming for health system financial sustainability and resilience to macroeconomic challenges.

It is the most densely populated country with the lowest total population of any EU member healthcare value chain Life expectancy compares well with the EU average and has improved over the past 20 years.

  • Value Chains of Public and Private Health-care Services in a Small EU Island State: A SWOT Analysis
  • Introduction

Inlife expectancy at birth: The Maltese health-care system is composed of the public sector, which is free at the point of use for all Maltese citizens and migrants residing in Malta, who are covered by Maltese social security legislation.

Excluded from this entitlement are elective dental care, optical services, and some formulary medicines, which are means-tested as per the non-contributory scheme of the Social Security Act Chapter of the Healthcare value chain of Malta 15 Individuals that fall within the low-income bracket are entitled to free medicines from healthcare value chain restricted National Health Service NHS formulary of essential medicines and to certain medical devices.

Value Chains of Public and Private Health-care Services in a Small EU Island State: A SWOT Analysis

In addition, chronic illnesses included in a specific schedule incorporated in the Social Security Act are covered by entitlement to free medicines related to healthcare value chain illness.

Renowned Harvard economist, Michael Porter, has been researching this notion for quite some time now.

He describes the term healthcare value chain chain as a collection of processes, inputs and outputs that take place to produce a product or service. This includes the entire production chain—from the supply of raw materials, healthcare value chain the production, to the distribution, and to the eventual delivery of the product to the consumer.

By mapping an organisations value chain, one can clearly identify where the most value is being added, where costs are greatest, and where inefficiencies reside.

Understanding a Value Chain in Health Care.

Healthcare systems have typically grown over time, leading to high levels of duplication of providers and very disjointed services in general. However, the complexities begin to emerge when, on top of all of this, you include the many different levels of Government, their policies, vested interests and, of course, the secondary industries such as private providers and insurance companies.

This complex, interdependent healthcare value chain chain causes the synchronicity between each link to be impeded, making it difficult to see the true value of the care healthcare value chain delivered—and its true cost. The question then becomes, how and whether we can deliver the same standard of care at a healthcare value chain cost?

Related Post